ConvaTec Group PLC (LON:CTEC - Get Free Report) insider Jonny Mason bought 50,000 shares of the firm's stock in a transaction on Thursday, August 28th. The stock was purchased at an average cost of GBX 235 per share, with a total value of £117,500.
ConvaTec Group Stock Performance
Shares of LON CTEC traded up GBX 3.20 during mid-day trading on Friday, hitting GBX 236.60. The company had a trading volume of 4,312,350 shares, compared to its average volume of 13,561,158. The company has a market capitalization of £4.84 billion, a price-to-earnings ratio of 2,232.08, a P/E/G ratio of 0.93 and a beta of 0.64. ConvaTec Group PLC has a 1 year low of GBX 211.80 and a 1 year high of GBX 311.20. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The stock's 50-day moving average price is GBX 247.82 and its 200-day moving average price is GBX 258.10.
Analyst Ratings Changes
CTEC has been the subject of several recent research reports. Peel Hunt reiterated an "add" rating and issued a GBX 280 price target on shares of ConvaTec Group in a research report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 315 price target on shares of ConvaTec Group in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reiterated an "overweight" rating on shares of ConvaTec Group in a research report on Wednesday, July 30th. Royal Bank Of Canada upgraded ConvaTec Group to an "outperform" rating and reduced their price target for the company from GBX 320 to GBX 315 in a research report on Thursday, August 21st. Finally, Berenberg Bank reduced their price target on ConvaTec Group from GBX 335 to GBX 330 and set a "buy" rating for the company in a research report on Tuesday, August 19th. Five analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of GBX 309.40.
Check Out Our Latest Research Report on ConvaTec Group
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Featured Stories
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.